A Novel Surface Modification Using Tissue Factor Reconstituted in Phospholipid Vesicles for the Activation of Blood Coagulation

Authors: Svedhem, Sofia1; Wikström, Angelica1; Deinum, Johanna2; Kasemo, Bengt1; Hansson, Kenny2

Source: Journal of Biomaterials Science, Polymer Edition, Volume 20, Number 1, 2009 , pp. 133-140(8)

Publisher: VSP, an imprint of Brill

Buy & download fulltext article:

OR

Price: $35.00 plus tax (Refund Policy)

Abstract:

We describe a novel method to immobilize recombinant human tissue factor (rhTF) reconstituted in phospholipid vesicles. The rhTF vesicles were immobilized in a multilayer vesicle structure using cholesterol-DNA tethers spontaneously inserted into the lipid membrane. The properties of the rhTF vesicle surface modification were characterized by surface plasmon resonance biosensor technology. As an application of this surface modification, we investigated its use as a blood coagulation activating surface. The coagulation activating capacity of the surface modification was tested by exposure to human whole blood in a flow chamber. No increase in rhTF levels in the blood was found after passage through the flow chamber, indicating that the rhTF surface modification was stable. Thrombin-antithrombin (TAT) and prothrombin fragment (PF) 1 + 2 levels increased after exposure to the surface, and decreased in a concentration-dependent way upon addition of melagatran (a direct thrombin inhibitor), i.e., coagulation activity triggered by rhTF could be suppressed by anticoagulation. The results with this new thrombogenic surface are promising, and will be further developed into a useful tool for coagulation related investigations, e.g., characterization of anticoagulants and biomaterials.

Keywords: TISSUE FACTOR; TETHERED LIPID VESICLES; CHOLESTEROL-DNA; BLOOD COAGULATION; FLOW CHAMBER

Document Type: Short communication

DOI: http://dx.doi.org/10.1163/156856208X386453

Affiliations: 1: Department of Applied Physics, Chalmers University of Technology, SE 412 96 Göteborg, Sweden 2: Department of Biosciences, AstraZeneca R&D, SE 431 83 Mölndal, Sweden

Publication date: 2009-01-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page